OssDsign AB is a developer and global provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the US, Germany, Sweden, the UK, the Rest of Europe, and the Rest of world. The company generates the majority of its revenue from the US.
2011
41
LTM Revenue $14.8M
LTM EBITDA -$4.0M
$124M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
OssDsign has a last 12-month revenue of $14.8M and a last 12-month EBITDA of -$4.0M.
In the most recent fiscal year, OssDsign achieved revenue of $13.3M and an EBITDA of -$4.9M.
OssDsign expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See OssDsign valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $11.1M | $13.3M | XXX | XXX | XXX |
Gross Profit | $4.5M | $8.3M | XXX | XXX | XXX |
Gross Margin | 40% | 62% | XXX | XXX | XXX |
EBITDA | -$10.2M | -$4.9M | XXX | XXX | XXX |
EBITDA Margin | -91% | -37% | XXX | XXX | XXX |
Net Profit | -$9.9M | -$13.0M | XXX | XXX | XXX |
Net Margin | -89% | -97% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, OssDsign's stock price is SEK 14 (or $1).
OssDsign has current market cap of SEK 1.3B (or $134M), and EV of SEK 1.2B (or $124M).
See OssDsign trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$124M | $134M | XXX | XXX | XXX | XXX | $-0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, OssDsign has market cap of $134M and EV of $124M.
OssDsign's trades at 8.4x LTM EV/Revenue multiple, and -30.6x LTM EBITDA.
Analysts estimate OssDsign's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for OssDsign and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $124M | XXX | XXX | XXX |
EV/Revenue | 9.3x | XXX | XXX | XXX |
EV/EBITDA | -25.2x | XXX | XXX | XXX |
P/E | -27.1x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -19.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOssDsign's NTM/LTM revenue growth is 34%
OssDsign's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, OssDsign's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate OssDsign's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for OssDsign and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 19% | XXX | XXX | XXX | XXX |
EBITDA Margin | -37% | XXX | XXX | XXX | XXX |
EBITDA Growth | -52% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -2% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 80% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 33% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 17% | XXX | XXX | XXX | XXX |
Opex to Revenue | 132% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OssDsign acquired XXX companies to date.
Last acquisition by OssDsign was XXXXXXXX, XXXXX XXXXX XXXXXX . OssDsign acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was OssDsign founded? | OssDsign was founded in 2011. |
Where is OssDsign headquartered? | OssDsign is headquartered in Sweden. |
How many employees does OssDsign have? | As of today, OssDsign has 41 employees. |
Is OssDsign publicy listed? | Yes, OssDsign is a public company listed on STO. |
What is the stock symbol of OssDsign? | OssDsign trades under OSSD ticker. |
When did OssDsign go public? | OssDsign went public in 2019. |
Who are competitors of OssDsign? | Similar companies to OssDsign include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of OssDsign? | OssDsign's current market cap is $134M |
What is the current revenue of OssDsign? | OssDsign's last 12-month revenue is $14.8M. |
What is the current EBITDA of OssDsign? | OssDsign's last 12-month EBITDA is -$4.0M. |
What is the current EV/Revenue multiple of OssDsign? | Current revenue multiple of OssDsign is 8.4x. |
What is the current EV/EBITDA multiple of OssDsign? | Current EBITDA multiple of OssDsign is -30.6x. |
What is the current revenue growth of OssDsign? | OssDsign revenue growth between 2023 and 2024 was 19%. |
Is OssDsign profitable? | Yes, OssDsign is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.